Mandel & Adriano Intellectual Property Attorneys
Home
About Us
Opinion
Staff
Links
News
Contact Us

 

 


     
 
 
1 7,335,748 Full-Text RG1 antibodies and uses thereof
2 7,332,332 Full-Text Buffer solution for electroporation and a method comprising the use of the same
3 7,320,859 Full-Text Modular transfection systems
4 7,312,032 Full-Text Methods for screening ligands that activate the translocation of a steroid receptor to the nucleus in mammalian cells
5 7,311,910 Full-Text Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions
6 7,307,154 Full-Text DNA encoding a novel RG1 polypeptide
7 7,304,033 Full-Text Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
8 7,300,915 Full-Text Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
9 7,300,761 Full-Text Methods and device for detecting prostate specific antigen (PSA)
10 7,183,255 Full-Text Method for stabilizing blood pressure in hemodialysis subjects
11 7,048,928 Full-Text Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
12 7,030,232 Full-Text E25A protein, methods for producing and use thereof
13 6,906,026 Full-Text Methods for treating conditions associated with the accumulation of excess extracellular matrix
14 6,899,895 Full-Text Lamellar gels and methods for making and regulating
15 6,858,150 Full-Text Water processing device with liquid seal
16 6,838,081 Full-Text Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient
17 6,830,937 Full-Text Method for generating and identifying antibodies directed against a B7
18 6,777,231 Full-Text Adipose-derived stem cells and lattices
19 6,764,825 Full-Text Methods and device for detecting prostate specific antigen (PSA)
20 6,756,036 Full-Text Methods for treating cancer using PSCA antibodies and fragments thereof
21 6,686,196 Full-Text Recombinant, modified adenoviral vectors for tumor specific gene expression and uses thereof
22 6,666,684 Full-Text Impression and foundation system for implant-supported prosthesis
23 6,663,858 Full-Text In Vivo gene transfer using implanted retroviral producer cells
24 6,663,857 Full-Text In vivo gene transfer using implanted retroviral producer cells
25 6,663,770 Full-Text Water processing device
26 6,645,728 Full-Text Inhibitor of the inflammatory response induced by TNF.alpha. and IL-1
27 6,641,809 Full-Text Method of regulating cellular processes mediated by B7 and CD28
28 6,627,200 Full-Text Utilization of CD 137 in order to promote the proliferation of peripheral monocytes
29 6,623,940 Full-Text Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
30 6,609,017 Full-Text Processed neural signals and methods for generating and using them
31 6,565,889 Full-Text Bilayer structure which encapsulates multiple containment units and uses thereof
32 6,541,212 Full-Text Methods for detecting prostate stem cell antigen protein
33 6,521,615 Full-Text Diagnosing an animal for pyrophosphate gout, osteoporosis, or osteoarthritis by assaying intracellular pyrophosphate content in peripheral blood cells
34 6,521,456 Full-Text Cellular transport system for the transfer of a nucleic acid through the nuclear envelope and methods thereof
35 6,517,839 Full-Text Methods for inducing interleukin-12 and a type1/Th1 T-cell response
36 6,465,627 Full-Text DAX-1 protein, methods for production and use thereof
37 6,455,300 Full-Text Method and compositions for monitoring DNA binding molecules in living cells
38 6,455,250 Full-Text Endonuclease compositions and methods of use
39 6,365,797 Full-Text Mice models of human prostate cancer progression
40 6,365,347 Full-Text Method for identifying disruptors of biological pathways using genetic selection
41 6,365,338 Full-Text Organ preservative solution containing trehalose, anti-oxidant, cations and an energy source
42 6,358,523 Full-Text Macromolecule-lipid complexes and methods for making and regulating
43 6,316,258 Full-Text Methods for preventing and treating fibrotic diseases resulting from accumulation of excess extracellular matrix induced by TGF.beta. using renin inhibitors
44 6,267,960 Full-Text PSCA: prostate stem cell antigen
45 6,265,538 Full-Text Inhibitor of the inflammatory response induced by the TNFA and IL-1
46 6,261,791 Full-Text Method for diagnosing cancer using specific PSCA antibodies
47 6,261,789 Full-Text Methods for detecting the presence of a PSCA protein using PSCA antibodies
48 6,258,939 Full-Text PSCA antibodies and hybridomas producing them
49 6,228,646 Full-Text Helper-free, totally defective adenovirus for gene therapy
50 6,221,861 Full-Text
 
51 6,221,401 Full-Text Bilayer structure which encapsulates multiple containment units and uses thereof
52 6,207,186 Full-Text Lamellar gels and methods for making and using
53 6,169,176 Full-Text Deoxynucleic alkyl thiourea compounds and uses thereof
54 6,136,965 Full-Text Deoxynucleic alkyl and alkoxy thiourea compounds
55 6,111,071 Full-Text Recombinant fusion protein comprising PDC-E2, BCOADC-E2 and OGDC-E2 and uses thereof
56 6,110,702 Full-Text PSA positive regulating (PSAR) sequences and uses thereof
57 6,107,540 Full-Text Mice models of human prostate cancer progression
58 6,093,800 Full-Text E25a protein, methods for production and use thereof
59 6,090,914 Full-Text CTLA4/CD28Ig hybrid fusion proteins and uses thereof
60 6,056,547 Full-Text Impression and foundation system for implant-supported prosthesis
61 6,030,830 Full-Text Immunoglobulin trans-spliced transcripts and uses thereof
62 6,013,785 Full-Text Polynucleoside chain having multiple ribonucleosides, the nucleosides coupled by guanidyl linkages
63 5,993,800 Full-Text Methods for prolonging the expression of a heterologous gene of interest using soluble CTLA4 molecules and an antiCD40 ligand
64 5,977,318 Full-Text CTLA4 receptor and uses thereof
65 5,968,510 Full-Text CTLA4 receptor and uses thereof
66 5,919,652 Full-Text Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof
67 5,916,560 Full-Text Methods for inhibiting an immune response by blocking the GP39/CD40 and CTLA4/CD28/B7 pathways and compositions for use therewith
68 5,885,579 Full-Text CTLA4 receptor and uses thereof
69 5,824,655 Full-Text Anti-transforming growth factor-.beta. gene therapy
70 5,773,253 Full-Text MYPPPY variants of CTL A4 and uses thereof
 		      
 

 

  

© 2006-2007 Mandel & Adriano. All Rights Reserved. Site Design by 100 Generators.